Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experienceRoelf Valkema, Eric P. Krenning, Marion de Jong et al.|Seminars in Nuclear Medicine|2002Cited by 433
Hypocalcemia and parathyroid hormone secretion in critically ill patientsLars Lind, Sverker Ljunghall, Fredrik Carlstedt et al.|Critical Care Medicine|2000Cited by 173
Catecholamine Release–Inhibitory Peptide Catestatin (Chromogranin A <sub>352–372</sub> )Fangwen Rao, Daniel T. O’Connor, Jiaur R. Gayen et al.|Circulation|2007Cited by 113
Heritability and Genome-Wide Linkage in US and Australian Twins Identify Novel Genomic Regions Controlling Chromogranin ADaniel T. O’Connor, John B. Whitfield, Gu Zhu et al.|Circulation|2008Cited by 87
Co‐expression of ghrelin and its receptor in pancreatic endocrine tumoursSara Ekeblad, Britt Skogseid, Margareta Halin Lejonklou et al.|Clinical Endocrinology|2006Cited by 49